Schedule 13G ownership disclosure

BIOAFFINITY TECHNOLOGIES INC

Common Stock, par value $0.007 per share · CUSIP: 09076W109

Event date: 2025-05-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Richard K. Crumly

    Shares: 3,213,777.00 · Class: 11.2%

  • ADAMAS LLC

    Shares: 400,027.00 · Class: 0.1%

  • BMUS PARTNERS LLC

    Shares: 10,000.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-048617
Form type
SCHEDULE 13G
Filer
Crumly Richard K.
CIK
CIK 1783794
Filed
May 14, 2025
Reporting period
May 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub